Opioid Class REMS: FDA Wants Prescriber/Pharmacist Certification

Public meeting set for end of May: next step on the difficult road to a class-wide REMS. Important precedent in the making.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet